+1 (321) 355-2686
LDD SP FOR RARE DISEASE
How a manufacturer was able to align multiple stakeholder needs to select the best Limited Distribution Specialty Pharmacy for their rare disease product
SITUATION
A large pharmaceutical manufacturer is preparing to launch a new rare disease product into the specialty space
The product is a refrigerated injectable with a small, adult, neurology patient population
Their team of 20+ stakeholders decided on a controlled, limited distribution model to provide ultimate patient experience
Stakeholders were from Trade and Distribution, Patient Services, Procurement, Market Access, and the Brand team
To select the best Limited Distribution Specialty Pharmacy partner, they hired Archbow to:
Develop a customized Specialty Pharmacy (SP) RFP document, Written Response Scorecard, and Bid Defense Scorecard
Issue, analyze, and score the RFP responses from 8 Specialty Pharmacies
An RFP was issued to 8 pre-qualified potential SP partners
Archbow collected and aggregated SP RFP responses from the participating SPs into a single document
A PDF Executive Summary for each SP, along with a reviewer scorecard, was provided to 20+ reviewers
Archbow analyzed the written responses, and included an aggregate pricing comparison
An aggregated weighted scorecard analysis was also provided in the readout
5 of the 8 SPs were invited to provide a virtual RFP Bid Defense presentation
A Bid Defense agenda was created for the SPs and a Bid Defense reviewer scorecard was provided to all stakeholders
An aggregated weighted scorecard analysis for the Bid Defenses was provided
APPROACH
RESULTS
All materials from all the SPs were collated into a single large PDF document
Archbow led a stakeholder review and discussion of the finalist presentations
3 SPs were listed as finalists and the pros and cons of each were explored
After working through Archbow’s RFP methodology, the stakeholders were able to align on the best
Limited Drug Distribution Network for their new rare disease product